VIMTALABS

Vimta Labs Ltd.

NSE: VIMTALABS

BSE: 524394

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Research, Analytics & Technology

537.95-14.8 (-2.67%)

8 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

93.4 / 100

Value Score

35.8 / 100

Price Momentum Score

51.1 / 100

QVM Score

68.2 / 100

Key Metrics

Market Cap

2403.94

P/E (TTM)

31.01

P/B

5.26

P/S (TTM)

5.90

EV/EBITDA

16.52

CAPE (5Y)

44.13

ROE (TTM)

18.55

ROCE (TTM)

23.07

ROA (TTM)

15.07

Avg 3Y ROE

17.16

Earnings 3Y CAGR

17.23

Sales 3Y CAGR

8.58

Sales 5Y CAGR

14.09

Debt/Equity

0.01

Consensus TP

743.00

Strong Buy %

Promoter Holding

35.85

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Vimta Labs Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

High and stable ROE

The company reported strong ROE of 18.55% for 12-month ended 31 Mar 2026 and ROE declined marginally by -73 bps from 1 year ago

What is ROE (FY)?

High and stable operating margin

The company reported strong operating margin of 24.0% for 12-month ended 31 Mar 2026 and operating margin declined marginally by -123 bps from 1 year ago

What is Operating profit margin?

Moderate revenue growth and above median growth of industry

The company delivered moderate revenue growth of 18.34% for 12-month ended 31 Mar 2026 and the growth was 11.45 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 6.89

Value 18.34

-32.8631.37

Moderate EPS growth and above median growth of industry

The company delivered moderate EPS growth of 16.22% for 12-month ended 31 Mar 2026 and the growth was 32.91 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.01 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 74.9 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

74.9 / 100

Consistently pays dividend

The company has not missed dividend payments once in the last 5 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at same valuation levels as industry median P/E

PE TTM of 31.01 indicates that the stock is expensive on a standalone basis. Discount to industry median P/E is modest at 0.0%

What is P/E Ratio?

Median: 31.01

Value 31.01

-222.33143.67

Low dividend yield

The company has a low dividend yield of 0.19%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Vimta Labs Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Vimta Labs Ltd. Shareholding Pattern

Quarterly breakdown of Vimta Labs Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.25	37.24	37.23	37.01	36.98	36.92	36.89	36.89	36.76	36.70	36.67	35.99	35.90	35.85
Indian Promoter	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.46	37.25	37.24	37.23	37.01	36.98	36.92	36.89	36.89	36.76	36.70	36.67	35.99	35.90	35.85
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.20	0.25	0.11	0.11	0.11	0.11	1.40	2.10	2.32	2.36	2.53	4.41	4.39	4.86	4.24	4.37	6.63	6.65	3.31	4.97	5.09	4.91	5.20	4.70	5.03
Mutual Funds / UTI	-	-	-	-	-	-	1.29	1.48	1.48	1.48	1.48	1.48	1.48	1.48	1.49	1.49	1.49	1.49	-	0.13	-	-	-	-	-
FI/Bank/Insurance	0.09	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.00	0.00	0.02	0.01	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.19	0.36	0.35	0.49	2.28	2.25	2.72	2.74	2.88	5.13	5.16	3.31	3.81	3.66	3.49	4.33	4.59	4.89
Other Institutions	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.44	0.48	0.53	0.56	0.65	0.66	0.66	0.00	0.00	0.00	0.00	0.00	1.00	1.42	1.42	0.87	0.11	0.13
Non-Institution	62.34	62.29	62.43	62.43	62.43	62.43	61.14	60.44	60.22	60.18	60.02	58.34	58.38	57.92	58.75	58.66	56.45	56.46	59.80	58.27	58.20	58.42	58.80	59.41	59.12
Bodies Corporate	32.77	31.78	30.84	32.20	31.86	31.05	31.02	31.33	30.99	30.74	30.70	30.70	30.58	30.61	30.74	30.56	30.67	30.70	30.95	30.74	30.54	30.35	30.23	30.16	30.28
Others (incl. Retail) No. of shareholders	29.57 10,354	30.51 12,303	31.59 12,174	30.23 11,286	30.57 12,019	31.38 20,787	30.12 19,823	29.11 19,052	29.23 18,196	29.44 17,971	29.32 18,147	27.64 18,752	27.80 17,015	27.31 17,279	28.01 18,253	28.10 19,791	25.78 18,358	25.76 18,867	28.85 19,894	27.53 20,877	27.66 25,877	28.07 30,506	28.57 55,578	29.25 54,127	28.84 51,344

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Biotech	2.29%	14 / 15

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Vimta Labs Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Harriman Vungal Promoter	February-2025	Market Sale (Disposal) 17th Feb 2025	7.99 %	₹ 1,083.66	2.90 k	₹ 31.43 lac
Harriman Vungal Promoter	February-2025	Market Sale (Disposal) 17th Feb 2025	7.99 %	₹ 1,083.66	2.90 k	₹ 31.43 lac
Harriman Vungal Promoter	February-2025	Market Sale (Disposal) 12th Feb 2025	8.00 %	₹ 1,038.00	975.00	₹ 10.12 lac
Dhanya Prakash Dhumal Designated Person	December-2024	Market Sale (Disposal) 6th Dec 2024	0.01 %	₹ 938.65	2.37 k	₹ 22.22 lac
Sujani Vasireddi Promoter Group	December-2024	Market Sale (Disposal) 6th Dec 2024	0.31 %	₹ 768.84	2.00 k	₹ 15.38 lac
Ravi Kumar Kunuguntla Designated Person	December-2024	Market Sale (Disposal) 4th Dec 2024	0.04 %	₹ 853.11	2.02 k	₹ 17.22 lac
Suresh Kumar S Designated Person	November-2024	Market Sale (Disposal) 27th Nov 2024	0.01 %	₹ 801.65	1.40 k	₹ 11.22 lac
Sujani Vasireddi Promoter Group	November-2024	Market Sale (Disposal) 27th Nov 2024	0.33 %	₹ 828.19	7.00 k	₹ 57.97 lac
Suresh Kumar S Designated Person	November-2024	Market Sale (Disposal) 19th Nov 2024	0.01 %	₹ 743.33	1.50 k	₹ 11.15 lac
D R Narahai Naidu KMP	November-2024	Market Sale (Disposal) 19th Nov 2024	0.02 %	₹ 767.35	3.66 k	₹ 28.08 lac

Corporate Actions

History of Vimta Labs Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 2/share
Record date: 18th Jun 2026Ex-date: 18th Jun 2026
Announced on: 6th May 2026
Bonus1 new shares for 1 existing shares
Ex-date: 13th Jun 2025Announced on: 28th Apr 2025
Estimated pay date.
Dividend₹ 2/share
Record date: 30th May 2025Ex-date: 30th May 2025
Announced on: 28th Apr 2025
Dividend₹ 2/share
Record date: 12th Jul 2024Ex-date: 11th Jul 2024
Announced on: 19th May 2024
Dividend₹ 2/share
Record date: 22nd Jun 2023Ex-date: 21st Jun 2023
Announced on: 3rd May 2023

Company Profile

Overview of Vimta Labs Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Vimta Labs Limited is an India-based contract research and testing services provider. The Company operates through the Contract Research and Testing Services segment. It is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, heal...

Key personnel

Shri. Siva Rama Krishna Kambhampati

Chief Financial Officer

Ms. Sujani Vasireddi

Company Secretary, Compliance officer

Dr. Sivalinga Prasad Vasireddi, Ph.D.D

Executive Chairman of the Board

Ms. Harita VasireddiD

Managing Director, Executive Director

Mr. Satya Sreenivas NeerukondaD

Executive Director

Shri. Harriman VungalD

Executive Director - Operations

Mr. Sanjay DaveD

Non-Executive Independent Director

Mr. Purnachandra Rao GuttaD

Non-Executive Independent Director

View all

Incorporated on

16 Nov 1990

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

1,384

IPO date

13 Sep 1993

Free Float

1,52,52,824

Website

https://vimta.com/

Phone no.

+914027264141

Address

Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, HYDERABAD, 500051, India

Frequently Asked Questions

What is the current share price of Vimta Labs Ltd.?

The current share price of Vimta Labs Ltd. is ₹ 537.95 as of 8 Jul 2026.

What is the market capitalisation of Vimta Labs Ltd.?

The market capitalisation of Vimta Labs Ltd. stands at ₹ 2,403.94 Cr.

What is the PE ratio of Vimta Labs Ltd.?

The Price-to-Earnings (PE) ratio of Vimta Labs Ltd. is 31.01 as of the latest trailing twelve months data.

What is the ROE and ROCE of Vimta Labs Ltd.?

Vimta Labs Ltd. has a Return on Equity (ROE) of 18.55% and a Return on Capital Employed (ROCE) of 23.07% as per the latest financial reports.

What is the 52-week high and low of Vimta Labs Ltd.?

The 52-week high of Vimta Labs Ltd. is - and the 52-week low is -.

What is the dividend yield of Vimta Labs Ltd.?

The dividend yield of Vimta Labs Ltd. is 0.19% based on the current market price.

What is the FII and DII holding in Vimta Labs Ltd.?

Foreign Institutional Investors (FII) hold 4.89%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 28.84% of Vimta Labs Ltd. shares.

What sector does Vimta Labs Ltd. belong to?

Vimta Labs Ltd. operates in the Healthcare sector.

What is the beta of Vimta Labs Ltd.?

The beta of Vimta Labs Ltd. is 1.15, indicating its price volatility relative to the broader market. Over the past 1 year, Vimta Labs Ltd. has delivered an absolute return of 19.64%.

What is the RSI of Vimta Labs Ltd.?

The 14-day Relative Strength Index (RSI) of Vimta Labs Ltd. is 46.21, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Vimta Labs Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Vimta Labs Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Company Profile

Corporate Actions